B cell maturation antigen‐specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta‐analysis-Reference-Cited by-同舟云学术

B cell maturation antigen‐specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta‐analysis

Published:2020-01-20 Issue:4 Volume:104 Page:318-327
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Gagelmann Nico¹,Ayuk Francis¹,Atanackovic Djordje²,Kröger Nicolaus¹^ORCID

Affiliation:

1. Department of Stem Cell Transplantation University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies University of Utah/Huntsman Cancer Institute Salt Lake City UT USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13380

Reference50 articles.

1. Cancer Stact Facts: Myeloma.National Cancer Institute Surveillance Epidemiology and End Results Program Website.2018.https://seer.cancer.gov/statfacts/html/mulmy.html. Accessed June 2 2019.

2. Multiple Myeloma

3. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

4. Systematic Literature Review and Network Meta-Analysis of Treatment Outcomes in Relapsed and/or Refractory Multiple Myeloma

5. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma;Journal of Nanobiotechnology;2024-05-23

2. Polymer Backpack‐Loaded Tissue Infiltrating Monocytes for Treating Cancer;Advanced Healthcare Materials;2024-04-25

3. Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature;Ophthalmic Plastic & Reconstructive Surgery;2024-03-21

4. Impact of Treatment Modality and Route of Administration on Cytokine Release Syndrome in Relapsed or Refractory Multiple Myeloma: A Meta‐Analysis;Clinical Pharmacology & Therapeutics;2024-03-08

5. Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future;International Journal of Molecular Sciences;2023-10-27